BHC Bausch Health Companies Inc.

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:BHC.

$27.31  -0.25 (-0.89%)
As of 09/17/2021 12:35:53 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Canada
Country of incorporation:  Canada
IPO date:  08/26/2013
Outstanding shares:  358,395,632
Average volume:  1,776,934
Market cap:   $10,092,420,997
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    071734107
ISIN:        CA0717341071
Sedol:      BFFVVC1
Valuation   (See tab for details)
PE ratio:   -7.67
PB ratio:   18.31
PS ratio:   1.19
Return on equity:   210.64%
Net income %:   -15.18%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy